The economic impact of anastomotic leak after colorectal cancer surgery.

Data de publicació: Data Ahead of Print:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Noguera-Aguilar, Jose Francisco
  • Delgado-Rivilla, Salvadora
  • Garcia-Gonzalez, Jose Maria
  • Rodriguez-Martin, Marcos
  • Salinas-Ortega, Laura
  • Casado, Miguel Angel
  • Alvarez, Maria

Grups d'Investigació

Abstract

OBJECTIVE: To determine the economic impact of the incremental consumption of resources for the diagnosis and treatment of anastomotic leak (AL) in patients after resection with anastomosis for colorectal cancer compared to patients without AL on the Spanish health system. METHOD: This study included a literature review with parameters validated by experts and the development of a cost analysis model to estimate the incremental resource consumption of patients with AL versus those without. The patients were divided into three groups: 1) colon cancer (CC) with resection, anastomosis and AL; 2) rectal cancer (RC) with resection, anastomosis without protective stoma and AL; and 3) RC with resection, anastomosis with protective stoma and AL. RESULTS: The average total incremental cost per patient was €38,819 and €32,599 for CC and RC, respectively. The cost of AL diagnosis per patient was €1018 (CC) and €1030 (RC). The cost of AL treatment per patient in Group 1 ranged from €13,753 (type B) to €44,985 (type C + stoma), that in Group 2 ranged from €7348 (type A) to €44,398 (type C + stoma), and that in Group 3 ranged from €6197 (type A) to €34,414 (type C). Hospital stays represented the highest cost for all groups. In RC, protective stoma was found to minimize the economic consequences of AL. CONCLUSIONS: The appearance of AL generates a considerable increase in the consumption of health resources, mainly due to an increase in hospital stays. The more complex the AL, the higher the cost associated with its treatment. INTEREST OF THE STUDY: it is the first cost-analysis study of AL after CR surgery based on prospective, observational and multicenter studies, with a clear, accepted and uniform definition of AL and estimated over a period of 30 days.

© 2023. The Author(s).

Dades de la publicació

ISSN/ISSNe:
2191-1991, 2191-1991

Health Economics Review  Springer Science and Business Media Deutschland GmbH

Tipus:
Article
Pàgines:
12-12
PubMed:
36795234
Factor d'Impacte:
0,535 SCImago
Quartil:
Q2 SCImago

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • Anastomotic leak; Colorectal cancer; Cost; Resection; Spain; Stoma

Projectes associats

Ileostomía vistual combinada con endoscopia postoperatoria ebn cáncer de recto con escisión total mesorrectal. ¿podemos evitar estomas innecesarios? estudio prospectivo observacional multicénctrico.

Investigador Principal: BLAS FLOR LORENTE

PI17/00863 . INSTITUTO DE SALUD CARLOS III . 2018

"TIMing Evaluation of Stoma closure” Cierre precoz vs tardío del estoma derivativo tras cirugía de cáncer de recto.

Investigador Principal: MATTEO FRASSON

2018_0078_CRC_FRASSON . ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA (AECP) . 2018

Trocar multisensor para cirugía laparoscópica con presión de pneumoperitoneo individualizada

Investigador Principal: ÓSCAR DÍAZ CAMBRONERO

INNVAL10/18/056 . AGENCIA VALENCIANA DE LA INNOVACION (AVI) . 2018

INDIVIDUALIZED PERIOPERATIVE HEMODYNAMIC GOAL-DIRECTED THERAPY IN MAJOR ABDOMINAL SURGERY (IPEGASUS-TRIAL).

Investigador Principal: ÓSCAR DÍAZ CAMBRONERO

IPEGASUS . 2017

MU OPIOID RECEPTOR 1 (MOR-1) EXPRESSION IN COLORECTAL CANCER AND DISEASE-FREE SURVIVAL RELATIONSHIP (MOROCCO). FIVE-YEAR FOLLOW-UP.

Investigador Principal: ÓSCAR DÍAZ CAMBRONERO

ODC-MOR-2018-01

PRESIÓN INDIVIDUALIZADA DE INSUFLACIÓN DEL PNEUMOPERITONEO EN CIRUGÍA LAPAROSCÓPICA COLORECTAL FRENTE A TERAPIA ESTÁNDAR.

Investigador Principal: ÓSCAR DÍAZ CAMBRONERO

IPPCOLLAPSE-II . 2016

Acute PresentatiOn of CoLorectaL Cancer: an internatiOnal snapshot An international, multi-centre study of emergency presentations of colorectal cancer.

Investigador Principal: JORGE SANCHO MURIEL

APOLLO . 2023

HEMO-FISSQoL - Traducción validada al español de un instrumento de medida de la calidad de vida en pacientes con patología hemorroidal y fisura anal.

Investigador Principal: HANNA BARBARA CHOLEWA

HEMO-FISSQoL . 2023

Estudio de seguimiento clínico poscomercialización de los dispositivos de aplicación de clips reutilizables y cartuchos para cirugía laparoscópica (RELAP).

Investigador Principal: ÓSCAR DÍAZ CAMBRONERO

PD01-227 . 2023

Compartir la publicació